Bayer to license Cedilla’s selective inhibitors in precision oncology
The license agreement provides Bayer with exclusive rights to develop and commercialise Cedilla’s CyclinE1/CDK2 inhibitors that are currently…
InDex Pharmaceuticals, Viatris sign deal to commercialise cobitolimod in Japan
01 Jun 23Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…
EU, Pfizer/BioNTech agree to amend existing Covid vaccine contract
29 May 23The amendments are the result of months of talks and amid pressure on Brussels from EU governments due…
Astellas, Sony announce research collaboration for ADC platform in oncology
17 May 23Astellas and Sony will jointly develop and optimise a new ADC platform using KIRAVIA Backbone as a linker,…
Gilead, Arcus expand research partnership to include inflammatory diseases
16 May 23Arcus will receive an upfront payment of $35m and will commence research programs against up to four targets,…
SERB obtains US rights to SFJ’s ticagrelor reversal agent bentracimab
12 May 23Bentracimab is a novel, monoclonal antibody fragment that reverses the antiplatelet activity of ticagrelor, an antiplatelet medicine marketed…
Nanobiotix in talks to develop and commercialise cancer drug NBTXR3
08 May 23The biotechnology company has entered negotiations with a major global pharmaceutical company, for the development and commercialisation of…
Moderna teams up with Novocol for fill-finish, packaging of mRNA vaccines in Canada
05 May 23Under the terms of the agreement, Novocol Pharma will provide fill-finish and packaging for vaccines manufactured at Moderna’s…
Volastra in-licenses Amgen’s sovilnesib; secures $60m funding
08 Mar 23The financing, led by founding investors Polaris Partners and ARCH Venture Partners alongside Lilly, will support Volastra’s portfolio…
FDB agrees to manufacture Argenx’s antibody therapy efgartigimod
28 Oct 22Under the agreement, FDB will provide drug substance manufacturing of efgartigimod at its large-scale biomanufacturing facility in Hillerød,…